Back to Results
First PageMeta Content
Drug rehabilitation / Alcohols / Euphoriants / Ketones / Buprenorphine / Drug Addiction Treatment Act / Methadone / Opioid dependence / Substance dependence / Chemistry / Organic chemistry / Morphinans


Microsoft Word - July[removed]FINAL_overview of Eval of the Bupe Waiver Progr.
Add to Reading List

Document Date: 2008-05-28 10:55:23

Open Document

File Size: 102,97 KB

Share Result on Facebook

City

Washington / DC / /

Company

Reckitt Benckiser / NDIC / Community Epidemiology Work Group / Purdue Pharma / /

Country

France / United States / /

Event

Person Communication and Meetings / /

Facility

Wayne State University / University of Texas / /

IndustryTerm

retail / informant network / Treatment of Opioid Disorders / law enforcement professionals / adjunctive services / /

MedicalCondition

drug abuse / substance abuse disorders / opiate addiction / /

Organization

National Drug Intelligence Center / SAMHSA’s office of Applied Studies / Food and Drug Administration / University of Texas at Austin / U.S. Department of Justice / Substance Abuse and Mental Health Services Administration’s Center for Substance Abuse Treatment / National Institute on Drug Abuse / Division of Pharmacologic Therapies / American Association for the Treatment of Opioid Disorders / office of Management and Budget / Wayne State University / Department of Health and Human Services / Payer/Provider Organization / Drug Enforcement Administration / /

Person

Jane Maxwell / /

Position

Secretary and Attorney General / Waivered Physician / Addiction Physician / physician / Attorney General / Secretary / /

Product

naloxone / Suboxone / Subutex / /

ProvinceOrState

Texas / /

SocialTag